Fig. 1
From: Targeting and limiting surgery for patients with node-positive breast cancer

Schema for the ACOSOG Z0011 Trial [4, 14]. The ACOSOG Z0011 trial was designed to determine whether there was a difference in overall survival or locoregional recurrence in early breast cancer with one or two positive sentinel lymph nodes who underwent axillary lymph node dissection versus those that had no further axillary therapy